NLRP3 and metabolic dysfunction-associated steatotic liver disease: Together, these results imply that NAFLD hepatic sEVs markedly activate Cathepsin B/NLRP3 inflammasome axis, which in turn promote HMGB1 release and induce microvascular endothelial hyperpermeability.